Annals of Oncology

Editorials:

Paolo Marchetti

Natural medicine: a ‘new frontier’ in oncology?
Ann Oncol 16: 339-340; doi:10.1093/annonc/mdi069
[Extract] [FREE Full Text] [PDF] [Request Permissions]

L. Sadler and P. Sykes

How little is known about cervical cancer in pregnancy?
Ann Oncol 16: 341-343; doi:10.1093/annonc/mdi139
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

J. P. C. Steele and A. Klabatsa

Chemotherapy options and new advances in malignant pleural mesothelioma
Annals of Oncology Advance Access published on January 27, 2005
Ann Oncol 16: 345-351; doi:10.1093/annonc/mdi094
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. G. Grevelman and W. P. M. Breed

Prevention of chemotherapy-induced hair loss by scalp cooling
Annals of Oncology Advance Access published on January 10, 2005
Ann Oncol 16: 352-358; doi:10.1093/annonc/mdi088
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Breast Cancer:

J. A. Menendez, L. Vellon, R. Colomer, and R. Lupu

Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin^TM) in breast cancer cells with Her-2/neu oncogene amplification
Annals of Oncology Advance Access published on January 10, 2005
Ann Oncol 16: 359-371; doi:10.1093/annonc/mdi090
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

N. de Jong, M. J. J. M. Candel, H. C. Schouten, H. Huijer Abu-Saad, and A. M. Courtens

Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy
Annals of Oncology Advance Access published on January 27, 2005
Ann Oncol 16: 372-382; doi:10.1093/annonc/mdi095
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

U. Veronesi, R. Orecchia, S. Zurrida, V. Galimberti, A. Luini, P. Veronesi, G. Gatti, G. D'Aiuto, L. Cataliotti, R. Paolucci, P. Piccolo, N. Massaioli, P. Sismondi, A. Rulli, F. Lo Sardo, A. Recalcati, D. Terribile, A. Acerbi, N. Rotmensz, P. Maisonneuve, and GrISO (Italian Oncological Senology Group)

Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 383-388; doi:10.1093/annonc/mdi089
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Arriagada, M. G. Lê, M. Spielmann, L. Mauriac, J. Bonneterre, M. Namer, T. Delozier, C. Hill, and T. Tursz

Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
Annals of Oncology Advance Access published on January 27, 2005
Ann Oncol 16: 389-396; doi:10.1093/annonc/mdi085
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

N. Germann, C. Haie-Meder, P. Morice, C. Lhomme, P. Duvillard, K. Hacene, and A. Gerbaulet

Management and clinical outcomes of pregnant patients with invasive cervical cancer
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 397-402; doi:10.1093/annonc/mdi084
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Fauvet, J. Boccara, C. Dufournet, C. Poncelet, and E. Daraï

Laparoscopic management of borderline ovarian tumors: results of a French multicenter study
Annals of Oncology Advance Access published on January 14, 2005
Ann Oncol 16: 403-410; doi:10.1093/annonc/mdi083
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Urogenital tumors:

J.-P. Lotz, B. Bui, F. Gomez, C. Théodore, A. Caty, K. Fizazi, G. Gravis, R. Delva, J. Peny, P. Viens, B. Duclos, T. De Revel, H. Curé, J. Gligorov, S. Guillemaut, C. Ségura, S. Provent, J.-P. Droz, S. Culine, and P. Biron On behalf of the Groupe d'Etudes des Tumeurs Uro-Génitales (GETUG)

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
Annals of Oncology Advance Access published on January 19, 2005
Ann Oncol 16: 411-418; doi:10.1093/annonc/mdi087
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Font, A. Murias, F. R. García Arroyo, C. Martin, J. Areal, J. J. Sanchez, J. A. Santiago, M. Constenla, J. M. Saladie, and R. Rosell

Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 419-424; doi:10.1093/annonc/mdi096
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

T. Delaunoit, S. R. Alberts, D. J. Sargent, E. Green, R. M. Goldberg, J. Krook, C. Fuchs, R. K. Ramanathan, S. K. Williamson, R. F. Morton, and B. P. Findlay

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
Annals of Oncology Advance Access published on January 27, 2005
Ann Oncol 16: 425-429; doi:10.1093/annonc/mdi092
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

Y. Ohe, S. Negoro, K. Matsui, K. Nakagawa, T. Sugiura, Y. Takada, Y. Nishiwaki, S. Yokota, M. Kawahara, N. Saijo, M. Fukuoka, and Y. Ariyoshi On behalf of the Amrubicin SCLC Study Group

Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
Annals of Oncology Advance Access published on January 14, 2005
Ann Oncol 16: 430-436; doi:10.1093/annonc/mdi081
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Sarcomas:

E. L. Spurrell, C. Fisher, J. M. Thomas, and I. R. Judson

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital
Annals of Oncology Advance Access published on January 14, 2005
Ann Oncol 16: 437-444; doi:10.1093/annonc/mdi082
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

K. Jahnke, A. Korfel, P. Martus, M. Weller, U. Herrlinger, A. Schmittel, L. Fischer, and E. Thiel On behalf of the German Primary Central Nervous System Lymphoma Study Group (G-PCNSL-SG)

High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
Annals of Oncology Advance Access published on January 14, 2005
Ann Oncol 16: 445-449; doi:10.1093/annonc/mdi075
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Spectre, A. Gural, G. Amir, A. Lossos, T. Siegal, and O. Paltiel

Central nervous system involvement in indolent lymphomas
Annals of Oncology Advance Access published on January 10, 2005
Ann Oncol 16: 450-454; doi:10.1093/annonc/mdi076
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. J. Liu, R. W. Huang, D. J. Lin, J. Peng, X. Y. Wu, Q. Lin, X. L. Pan, Y. Q. Song, M. H. Zhang, M. Hou, and F. Chen

Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor- ligands induces apoptosis on human myeloid leukemia cells in vitro
Annals of Oncology Advance Access published on January 10, 2005
Ann Oncol 16: 455-459; doi:10.1093/annonc/mdi077
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. B. Lens and J. A. Newton-Bishop

An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review
Annals of Oncology Advance Access published on January 10, 2005
Ann Oncol 16: 460-465; doi:10.1093/annonc/mdi080
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Foussard, P. Colombat, H. Maisonneuve, C. Berthou, R. Gressin, M.-C. Rousselet, P. Rachieru, B. Pignon, B. Mahé, C. Ghandour, B. Desablens, P. Casassus, T. Lamy, V. Delwail, and E. Deconinck On behalf of the Groupe Ouest-Est des Leucémies et Autres Maladies du Sang (GOELAMS)

Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies
Annals of Oncology Advance Access published on February 2, 2005
Ann Oncol 16: 466-472; doi:10.1093/annonc/mdi091
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

K. P. Beal, H. W. Yeung, and J. Yahalom

FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 473-480; doi:10.1093/annonc/mdi093
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

P. Boyle and J. Ferlay

Cancer incidence and mortality in Europe, 2004
Annals of Oncology Advance Access published on February 17, 2005
Ann Oncol 16: 481-488; doi:10.1093/annonc/mdi098
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Bosetti, M. Malvezzi, L. Chatenoud, E. Negri, F. Levi, and C. La Vecchia

Trends in cancer mortality in the Americas, 1970–2000
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 489-511; doi:10.1093/annonc/mdi086
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

D Tripathy

Reply to "Letter to the Editor on ‘Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial"’, by A. M. Westermann doi:10.1093/annonc/mdi072
Annals of Oncology Advance Access published on February 2, 2005
Ann Oncol 16: 513; doi:10.1093/annonc/mdi071
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. M. Westermann

Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 513; doi:10.1093/annonc/mdi072
[Extract] [FREE Full Text] [PDF] [Request Permissions]

V. Garipidou, S. Vakalopoulou, E. Zafiriadou, V. Kaloutsi, K. Tziomalos, and V. Perifanis

Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease
Annals of Oncology Advance Access published on January 24, 2005
Ann Oncol 16: 514-515; doi:10.1093/annonc/mdi073
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Herr, S. Borelli, W. Kempf, and A. Trojan

Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?
Annals of Oncology Advance Access published on January 27, 2005
Ann Oncol 16: 515-516; doi:10.1093/annonc/mdi074
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. Fabi, G. Ferretti, N. Salesi, P. Papaldo, P. Carlini, M. Ciccarese, B. Di Cocco, F. Cecere, C. Nardoni, A. Felici, and F. Cognetti

Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?
Annals of Oncology Advance Access published on January 10, 2005
Ann Oncol 16: 516-517; doi:10.1093/annonc/mdi078
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

P. Jacobs and L. Wood

Biology and Management of Multiple Myeloma
Ann Oncol 16: 519; doi:10.1093/annonc/mdi079
[Extract] [FREE Full Text] [PDF] [Request Permissions]

H. H. Hansen

Tobacco and Public Health: Science and Policy
Ann Oncol 16: 520; doi:10.1093/annonc/mdi097
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.